Pharmacogenomics and Personalized Medicine in Neuropsychiatry

Francis J. McMahon; Thomas R. Insel

doi:10.1016/j.neuron.2012.05.004

Pharmacogenomics and Personalized Medicine in Neuropsychiatry

Francis J. McMahon, Thomas R. Insel

Research output: Contribution to journal › Short survey › peer-review

52 Scopus citations

Abstract

Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

Original language	English (US)
Pages (from-to)	773-776
Number of pages	4
Journal	Neuron
Volume	74
Issue number	5
DOIs	https://doi.org/10.1016/j.neuron.2012.05.004
State	Published - Jun 7 2012
Externally published	Yes

ASJC Scopus subject areas

General Neuroscience

Access to Document

10.1016/j.neuron.2012.05.004

Cite this

@article{30fccdc90bac4faca678d30ade2fab9d,

title = "Pharmacogenomics and Personalized Medicine in Neuropsychiatry",

abstract = "Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.",

author = "McMahon, {Francis J.} and Insel, {Thomas R.}",

note = "Funding Information: This work was supported by the NIMH Intramural Research Program. We thank Gonzalo Laje for helpful comments.",

year = "2012",

month = jun,

day = "7",

doi = "10.1016/j.neuron.2012.05.004",

language = "English (US)",

volume = "74",

pages = "773--776",

journal = "Neuron",

issn = "0896-6273",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Pharmacogenomics and Personalized Medicine in Neuropsychiatry

AU - McMahon, Francis J.

AU - Insel, Thomas R.

N1 - Funding Information: This work was supported by the NIMH Intramural Research Program. We thank Gonzalo Laje for helpful comments.

PY - 2012/6/7

Y1 - 2012/6/7

N2 - Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

AB - Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

UR - http://www.scopus.com/inward/record.url?scp=84861940981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861940981&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2012.05.004

DO - 10.1016/j.neuron.2012.05.004

M3 - Short survey

C2 - 22681682

AN - SCOPUS:84861940981

SN - 0896-6273

VL - 74

SP - 773

EP - 776

JO - Neuron

JF - Neuron

IS - 5

ER -

Pharmacogenomics and Personalized Medicine in Neuropsychiatry

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this